Publication date: Available online 5 November 2026 Source: Research and Practice in Thrombosis and Haemostasis Author(s): Ella I. Ertekin, Fabius Pelzer, Behnaz Pezeshkpoor, Paul Knöbl, Christian Pfrepper, Richard Greil, Johannes Oldenburg, Ulrich Sachs, Wolfgang Miesbach, Karolin Trautmann-Grill, Christina Hart, Robert Klamroth, Sonja Werwitzke, Andreas Tiede, Olga Oleshko
Incidence of anti-drug antibodies against emicizumab in acquired hemophilia A: Results from the GTH-AHA-EMI Study. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926037106?dgcid=rss_sd_all
Incidence of anti-drug antibodies against emicizumab in acquired hemophilia A: Results from the GTH-AHA-EMI Study. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926037106?dgcid=rss_sd_all
“Incidence of anti-drug antibodies against emicizumab in acquired hemophilia A: Results from the GTH-AHA-EMI Study.” Research and Practice in Thrombosis and Haemostasis.
@article{article64305,
title = {Incidence of anti-drug antibodies against emicizumab in acquired hemophilia A: Results from the GTH-AHA-EMI Study},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926037106?dgcid=rss_sd_all}
}